Work

The clinical need for clustered AChR cell-based assay testing of seronegative MG

Year: 2022

Type: article

Study design: Observational Study

Source: Journal of Neuroimmunology

DOI: 10.1016/j.jneuroim.2022.577850

Authors: Gianvito Masi, Yingkai Li, Tabitha Karatz, Minh C. Pham, Seneca R. Oxendine, Richard J. Nowak, Jeffrey T. Guptill, Kevin C. O'Connor

Institutions: Yale University, Duke University, Duke Medical Center, Duke Clinical Research Institute

Language: English

Topic: Myasthenia Gravis and Thymoma

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Myasthenia Gravis Foundation of America, Takeda Pharmaceuticals U.S.A., National Institutes of Health, Centers for Disease Control and Prevention, Genentech, National Institute of Mental Health, National Institute of Allergy and Infectious Diseases, National Institute of Neurological Disorders and Stroke, National Center for Advancing Translational Sciences, UCB Pharma

Awards: G3426671974, Molecular determinants driving diverse mechanisms of antibody-mediated pathology, Rare Disease Network for Myasthenia Gravis, Interdisciplinary Immunology Training Program, Yale Clinical and Translational Science Award, Mechanisms of autoimmunity in myasthenia gravis

OpenAlex ID: W4221066643

FWCI: 3.421

Cites: 18

Cited by: 31

Related to: 10